猛料视频

The surgical science highlighted in this curated collection of articles explores the latest advancements in breast cancer research and covers a wide range of topics related to breast cancer treatment, from impact of healthcare policy to clinical trials and innovative surgical techniques.

A glimpse inside this collection:

• Disparities in Care: Several articles address racial, ethnic, and socioeconomic disparities in breast cancer presentation, treatment options, and outcomes.
• Treatment Strategies: Explore studies on neoadjuvant therapy, axillary nodal response, and potential alternatives to traditional breast surgery.
• Patient Experience: Gain insights from research on postoperative complications, quality of life after treatment, and the psychological impact of breast cancer recurrence.
• Emerging Technologies: Discover the potential of circulating microRNAs as diagnostic tools and the use of advanced technologies in breast cancer surgery.

We encourage you to explore these articles and gain a deeper understanding of the ongoing efforts to improve breast cancer diagnosis, treatment, and patient well-being.

Scroll to the CME Articles section for opportunities to earn聽AMA PRA Category 1 Credits鈩� related to this collection.聽

April 2025

• Breast Conservation Surgery for Breast Cancer in Men

September 2024

• Current Status of Contralateral Prophylactic Mastectomy: Investigating Structural Racial Disparity

January 2024

• Long-Term Outcomes and Predictors of Response in Breast Cancer Patients with Advanced Nodal Involvement

Episode 29: Refractory and Recurrent Idiopathic Granulomatous Mastitis Treatment: Adaptive, Randomized Clinical Trial聽聽聽聽聽聽

聽聽聽聽聽聽聽聽聽聽聽聽聽聽聽 聽聽聽聽聽聽聽聽聽聽聽聽聽聽聽

In this episode, Lillian Erdahl, MD, FACS, is joined by Fatemeh Shojaeian, MD, MPH, from the Johns Hopkins University School of Medicine. They discuss Dr Shojaeian鈥檚 , 鈥淩efractory and Recurrent Idiopathic Granulomatous Mastitis Treatment: Adaptive, Randomized Clinical Trial,鈥� in which the authors found that, for resistant or relapsing patients with idiopathic granulomatous mastitis, combining methotrexate and corticosteroids offers a promising strategy. This integration of disease-modifying antirheumatic drugs with corticosteroids not only reduces the necessity for high steroid doses but also effectively alleviates associated side effects.